SKU	Name	Unit	Price	Delivery	QTY
SE121	Flunixin meglumine monoclonal antibody	1mg	$667.6	10days
TA102	Flunixin meglumine BSA antigen	1mg	$266.6	10days

SKU

Name

Unit

Price

Delivery

QTY

SE121

Flunixin meglumine monoclonal antibody

1mg

$667.6

10days

TA102

Flunixin meglumine BSA antigen

1mg

$266.6

10days

Description Operation References

AccuSift provides high‑performance flunixin meglumine competitive assay pairings, characterized by exceptional batch‑to‑batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.

Flunixin meglumine is a non‑steroidal anti‑inflammatory drug specifically for veterinary use. As a cyclooxygenase inhibitor, it exerts anti‑inflammatory, analgesic, and antipyretic effects by reducing prostaglandin production. It is included in the British Veterinary Pharmacopoeia and the United States Pharmacopoeia.

Clinically, it is indicated for the treatment of bovine respiratory disease, acute mastitis, porcine respiratory disease, and mastitis‑metritis‑agalactia syndrome. It is also used to relieve colic in horses and to treat diarrhea, tremors, colitis, and respiratory diseases in foals. Administration routes include intravenous and intramuscular injection.

Performance Characteristics:

Sensitivity: ELISA IC50: 0.2 ppb; Colloidal Gold: 1 ppb
Source: Mouse Monoclonal Antibody
Purity: ≥ 90%
Recommended Pairing: (Coating) / (Labeling)
Storage: Long‑term storage at ≤ –20°C; short‑term storage at 2–8°C. Shipped on ice packs.

Flunixin meglumine Competitive Antibody Pair

Operation

References